Literature DB >> 31780052

Indoor PM2.5, tobacco smoking and chronic lung diseases: A narrative review.

Yingmeng Ni1, Guochao Shi1, Jieming Qu2.   

Abstract

The lung is one of the most important organs exposed to environmental agents. People spend approximately 90% of their time indoors, and risks to health may thus be greater from exposure to poor air quality indoors than outdoors. Multiple indoor pollutants have been linked to chronic respiratory diseases. Environmental tobacco smoke (ETS) is known as an important source of multiple pollutants, especially in indoor environments. Indoor PM2.5 (particulate matter with aerodynamic diameter < 2.5 μm) was reported to be the most reliable marker of the presence of tobacco smoke. Recent studies have demonstrated that PM2.5 is closely correlated with chronic lung diseases. In this paper, we reviewed the relationship of tobacco smoking and indoor PM2.5 and the mechanism that underpin the link of tobacco smoke, indoor PM2.5 and chronic lung diseases.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; COPD; Chronic lung diseases; Environment tobacco smoke; Indoor PM(2.5); Lung cancer

Mesh:

Substances:

Year:  2019        PMID: 31780052     DOI: 10.1016/j.envres.2019.108910

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  10 in total

1.  E-cigarette Solvent Ratio and Device Power Influence Ambient Air Particulate Matter.

Authors:  Alisha Eversole; Melanie Crabtree; Tory R Spindle; Mohamad Baassiri; Thomas Eissenberg; Alison Breland
Journal:  Tob Regul Sci       Date:  2021-05

2.  Systematic review of changed smoking behaviour, smoking cessation and psychological states of smokers according to cigarette type during the COVID-19 pandemic.

Authors:  Hae-Ryoung Chun; Eunsil Cheon; Ji-Eun Hwang
Journal:  BMJ Open       Date:  2022-06-14       Impact factor: 3.006

3.  Exposure of Individuals in Europe to Air Pollution and Related Health Effects.

Authors:  Naixin Li; Rainer Friedrich; Christian Schieberle
Journal:  Front Public Health       Date:  2022-05-25

4.  Biomarkers and indoor air quality: A translational research review.

Authors:  Araliya M Senerat; Sheila M Manemann; Nicholas S Clements; Robert D Brook; Leslie C Hassett; Véronique L Roger
Journal:  J Clin Transl Sci       Date:  2020-09-04

5.  Joint association of cigarette smoking and PM2.5 with COPD among urban and rural adults in regional China.

Authors:  Jian Su; Qing Ye; Dandan Zhang; Fei Xu; Jinyi Zhou; Ran Tao; Zhen Ding; Gan Lu; Jiannan Liu
Journal:  BMC Pulm Med       Date:  2021-03-15       Impact factor: 3.317

Review 6.  Narrative review: association between lung cancer development and ambient particulate matter in never-smokers.

Authors:  Jeong Uk Lim; Hyoung Kyu Yoon
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

7.  Risk factors on healthcare-associated infections among tuberculosis hospitalized patients in China from 2001 to 2020: a systematic review and meta-analysis.

Authors:  Xinliang Liu; Nili Ren; Zheng Feei Ma; Meiling Zhong; Hao Li
Journal:  BMC Infect Dis       Date:  2022-04-20       Impact factor: 3.667

Review 8.  Indoor Air Pollution and Decision-Making Behavior: An Interdisciplinary Review.

Authors:  German Torres; Mervat Mourad; Joerg R Leheste
Journal:  Cureus       Date:  2022-06-23

9.  Health benefit/burden, PM2 .5 removal effectiveness, and power consumption based comparison of common residential air-cleaning technologies in the United States.

Authors:  Saloni Vijay; Jing Wang
Journal:  Indoor Air       Date:  2022-07       Impact factor: 6.554

10.  Field measurements of indoor and community air quality in rural Beijing before, during, and after the COVID-19 lockdown.

Authors:  Xiaoying Li; Jill Baumgartner; Sam Harper; Xiang Zhang; Talia Sternbach; Christopher Barrington-Leigh; Collin Brehmer; Brian Robinson; Guofeng Shen; Yuanxun Zhang; Shu Tao; Ellison Carter
Journal:  Indoor Air       Date:  2022-08       Impact factor: 6.554

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.